Pelizaeus-Merzbacher disease
Pelizaeus-Merzbacher disease (PMD) is an X-linked leukodystrophy which is characterized by an arrest in myelin development.
On this page:
Clinical presentation
Patients may present with
- pendular eye movements (nystagmus)
- hypotonia
- pyramidal disease
- ataxia
Pathology
Genetics
Pelizaeus-Merzbacher disease is the result of abnormalities of the proteolipidprotein (PLP1) gene locus at Xq22. This can be either a mutation, deletion or duplication (most common) 4.
Subtypes
Traditionally Pelizaeus-Merzbacher disease has divided into two subtypes:
- classic
- connatal: more rare and severe 5
Radiographic features
CT
CT features, as is the case with many leukodystrophies, are non-specific and may show hypoattenuating white matter with progressive white matter atrophy.
MRI
Features include:
- T1: lack of myelination, often seen as low T1 signal regions typically involving internal capsule, proximal corona radiata and the optic radiation
-
T2: near complete absence of expected low signal in the supratentorial region
- abnormal signal can either be diffuse or patchy
- if there is patchy involvement, a characteristic tigroid appearance may be seen 5
- may also show cortical sulcal prominence due to atrophy 4
- white matter volume may be decreased 4
- may also involve cerebellum and brainstem 4
-
MR spectroscopy
- affected areas often show a reduction in the NAA peak 4
- decreased choline (due to hypomyelination) 4
History and etymology
Named after Friedrich Christoph Pelizaeus (1851 - 1942), a German neurologist, and Ludwig Merzbacher (1875–1942), an Italian neuropathologist and psychiatrist.
Differential diagnosis
Although numerous other leukodystrophies are in the general differentials, specific entities to be considered include:
- Pelizaeus-Merzbacher-like disease (mutations of GJA12 at 1q41-q42 or MCT8 at Xq13.2)
- 18q- deletion (18q22.3 q23)
- Salla disease (SLC17A5 gene at 6q14-q15).
Related Radiopaedia articles
White matter disorders
- white matter
- normal myelination
- terminology
-
white matter disorders
-
demyelination
- anti-MOG associated encephalomyelitis
- Guillain-Barré syndrome (GBS)
- chronic inflammatory demyelinating polyneuropathy (CIDP)
- transverse myelitis
- tumefactive demyelinating lesions
- acute disseminated encephalomyelitis (ADEM)
- acute hemorrhagic encephalomyelitis (AHEM)
- neuromyelitis optica (NMO) (Devic disease)
-
multiple sclerosis (MS)
-
McDonald diagnostic criteria for MS (current 2017 revision)
- previous 2016 MAGNIMS consensus
- signs
- variants
-
McDonald diagnostic criteria for MS (current 2017 revision)
- radiologically isolated syndrome (RIS)
- clinically isolated syndrome (CIS)
- astrocytopathies
- leukoaxonopathies
- early-onset neuronal degenerative disorders
- giant axonal neuropathy
- hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)
- hypomyelination with congenital cataract
- leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
- hypomyelination with brainstem and spinal cord involvement and leg spasticity
- pol III-related leukodystrophies
- leukovasculopathies
- microgliopathies
- myelin disorders
- hypomyelination
- demyelination
- myelin vacuolisation
- other
- adult-onset autosomal dominant leukodystrophy
- cerebrotendinous xanthomathosis
- cystic leukoencephalopathy without megalencephaly
- L-2-hydroxyglutaric aciduria
-
lysosomal storage diseases
- free sialic acid storage disorders (e.g. Salla disease)
- Niemann-Pick disease
- peroxisomal disorders
- Sjögren-Larsson syndrome
-
demyelination